基于补体替代途径对小鼠结直肠癌肝转移模型调控作用的生物信息学分析及实验验证

doi:10.13481/j.1671-587X.20250315

Abstract

Abstract:

Objective To discuss the regulatory role of complement alternative pathway in mouse colorectal cancer （CRC） liver metastasis model based on bioinformatics methods， and to clarify its mechanism through experimental verification. Methods Using “CRC liver metastasis” as the keyword， the GSE81558 dataset was retrieved from Gene Expression Omnibus （GEO） database， including normal colon tissue samples， CRC tissue samples and CRC liver metastasis tissue samples. Bioinformatics methods were used to analyze and screen differentially expressed genes （DEGs）. Gene Ontology （GO） functional enrichment analysis and Kyoto Encyclopedia of Genes and Genomes （KEGG） pathway enrichment analysis were performed using R and Cytoscape software， and the results were visualized. Search Tool for the Retrieval of Interacting Genes/Proteins （STRING） database was used to evaluate protein-protein interactions （PPIs） of DEGs and construct PPI network. Twelve C57BL/6 mice were injected with SL4 tumor cells into spleen， and the liver tissues were collected at 0， 7 and 14 d. Real-time fluorescence quantitative PCR （RT-qPCR） method was used to detect the expression levels of complement pathway-related genes in liver metastatic foci. The CRC liver metastasis mouse model was used to verify the complement signaling pathway. The mice were divided into control group， factor B knockout group （FB^-/-） and C4 factor knockout group （C4^-/-）， and there were 6 mice in each group. The liver weights of the mice were measured； HE staining was used to detect the percentage of metastatic area in liver tissue in control group and FB^-/- group； immunohistochemistry was used to detect macrophage infiltration in liver tissue in control group and FB^-/- group， and the percentage of macrophage infiltration was calculated. Results The distances between normal colon tissue samples and CRC tissue samples， as well as between CRC tissue samples and CRC liver metastasis tissue samples were far， indicating significant differences between samples， allowing subsequent analysis of DEGs. A total of 1 908 DEGs were screened in the dataset comparing normal colon tissue samples and CRC tissue samples， including 771 up-regulated DEGs and 1 137 down-regulated DEGs. Twenty-three up-regulated DEGs and 100 down-regulated DEGs were identified in the dataset comparing CRC and CRC liver metastasis. The GO functional enrichment analysis results showed that compared with normal colon tissue samples， DEGs in CRC samples were mainly enriched in biological processes （BP） related to cell cycle and mitosis， including mitotic cell cycle process， cell division， response to hormone， mitotic nuclear division and response to lipid. Compared with CRC samples， the DEGs in CRC liver metastasis samples were mainly enriched in coagulation-related BP， including platelet degranulation， blood coagulation regulation， acute-phase response， hemostasis regulation and coagulation regulation. The KEGG pathway enrichment analysis results showed that compared with normal colon tissue samples， the DEGs in CRC tissue samples were mainly enriched in cell cycle and p53 signaling pathways. Compared with CRC tissue samples， the DEGs in CRC liver metastasis tissue samples were mainly enriched in complement， coagulation cascade and metabolism-related signaling pathways. The Hub genes identified in PPI network were related to blood proteins. The RT-qPCR results showed that compared with 0 d group， the mRNA expression level of complement related genes complement 1q （C1q） in liver metastatic foci tissue sampres in 7 d group was significantly decreased （P<0.05）， the mRNA expression levels of complement 3 （C3）， complement 5 （C5）， FB， and factor D （FD） were significantly increased （P<0.05 or P<0.01）， the mRNA expression levels of complement pathway-related genes C1q， complement 2 （C2）， C3， complement fragment 3a receptor （C3aR）， C5， complement fragment 5a receptor （C5aR）， decay-accelerating factor （DAF）， FB and FD in liver metastatic foci tissue sampres in 14 d group were significantly increased （P<0.05 or P<0.01）. Compared with control group， the liver weight of the mice in FB^-/- group was significantly decreased （P<0.01）， while there was no significant difference was observed in C4^-/- group （P>0.05）. The HE staining results showed that compared with control group， the liver metastatic foci in FB^-/- mice were significantly decreased， and the percentage of metastatic area was decreased （P<0.01）. The immunohistochemistry results showed that compared with control group， the macrophage infiltration in liver metastatic foci of the mice in FB^-/- group was reduced， and the percentage of macrophage infiltration was decreased （P<0.01）. Conclusion Complement cascade is associated with CRC liver metastasis， and the alternative complement pathway regulates CRC liver metastasis， suggesting this pathway may serve as a potential therapeutic target for CRC liver metastasis.

Key words: Colorectal cancer, Liver metastasis, Gene Expression Omnibus database, Bioinformatics, Differentially expressed genes

CLC Number:

R735.3

Changyu SHI,Yong LI,Jing DENG,Chunmei PIAO,Ming JIN. Bioinformatics analysis on adjustment effect of colorectal liver metastases model in mice based on complement alternative pathway and its experimental verification[J].Journal of Jilin University(Medicine Edition), 2025, 51(3): 703-715.

Figures/Tables 13

Tab.1

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

Fig. 7

Fig. 8

Fig. 9

Fig. 10

Fig. 11

Fig. 12

References 28

[1]	BENSON A B， VENOOK A P， AL-HAWARY M M， et al. Colon cancer， version 2.2021， NCCN clinical practice guidelines in oncology［J］. J Natl Compr Canc Netw， 2021， 19（3）： 329-359.
[2]	TSAI M S， SU Y H， HO M C， et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis［J］. Ann Surg Oncol， 2007， 14（2）： 786-794.
[3]	MAURI G， BONAZZINA E， AMATU A， et al. The evolutionary landscape of treatment for BRAF^V600E mutant metastatic colorectal cancer［J］. Cancers （Basel）， 2021， 13（1）： 137.
[4]	RUFFINELLI J C， SANTOS VIVAS C， SANZ-PAMPLONA R， et al. New advances in the clinical management of RAS and BRAF mutant colorectal cancer patients［J］. Expert Rev Gastroenterol Hepatol， 2021， 15（1）： 65-79.
[5]	LUO Q X， CHEN D K， FAN X J， et al. KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients： a single-site report［J］. Transl Oncol， 2020， 13（12）： 100874.
[6]	WANG D W， SU F， YANG L J， et al. Bioinformatics analysis and identification of potential genes associated with pathogenesis and prognosis of gastric cancer［J］. Curr Med Sci， 2022， 42（2）： 357-372.
[7]	TALAAT I M， ELEMAM N M， SABER-AYAD M. Complement system： an immunotherapy target in colorectal cancer［J］. Front Immunol， 2022， 13： 810993.
[8]	CHANG H L， JIN L， XIE P Y， et al. Complement C5 is a novel biomarker for liver metastasis of colorectal cancer［J］. J Gastrointest Oncol， 2022， 13（5）： 2351-2365.
[9]	PIAO C M， CAI L， QIU S L， et al. Complement 5a enhances hepatic metastases of colon cancer via monocyte chemoattractant protein-1-mediated inflammatory cell infiltration［J］. J Biol Chem， 2015， 290（17）： 10667-10676.
[10]	IRIZARRY R A， HOBBS B， COLLIN F， et al. Exploration， normalization， and summaries of high density oligonucleotide array probe level data［J］. Biostatistics， 2003， 4（2）： 249-264.
[11]	WEI R Q， ZHANG W M， LIANG Z， et al. Identification of signal pathways and hub genes of pulmonary arterial hypertension by bioinformatic analysis［J］. Can Respir J， 2022， 2022： 1394088.
[12]	RITCHIE M E， PHIPSON B， WU D， et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies［J］. Nucleic Acids Res， 2015， 43（7）： e47.
[13]	YOUNG A， WHITEHOUSE N， CHO J， et al. OntologyTraverser： an R package for GO analysis［J］. Bioinformatics， 2005， 21（2）： 275-276.
[14]	KANEHISA M. The KEGG database［J］. Novartis Found Symp， 2002， 247： 91-101； discussion101-103， 119-128， 244-252.
[15]	崔巍，杜杰，杨敏，等. 小鼠结直肠癌肝转移模型的建立及其炎症微环境分析［J］. 中国癌症杂志， 2012， 22（8）： 566-572， 582.
[16]	SCHILLING J D， MACHKOVECH H M， KIM A H J， et al. Macrophages modulate cardiac function in lipotoxic cardiomyopathy［J］. Am J Physiol Heart Circ Physiol， 2012， 303（11）： H1366-H1373.
[17]	HAN Y H， MUN J G， JEON H D， et al. Betulin inhibits lung metastasis by inducing cell cycle arrest， autophagy， and apoptosis of metastatic colorectal cancer cells［J］. Nutrients， 2019， 12（1）： 66.
[18]	MAREI H E， ALTHANI A， AFIFI N， et al. p53 signaling in cancer progression and therapy［J］. Cancer Cell Int， 2021， 21（1）： 703.
[19]	ADMASU F T， DEJENIE T A， AYEHU G W， et al. Evaluation of thromboembolic event， basic coagulation parameters， and associated factors in patients with colorectal cancer： a multicenter study［J］. Front Oncol， 2023， 13： 1143122.
[20]	KROONE C， TIEKEN C， KOCATÜRK B， et al. Tumor-expressed factor Ⅶ is associated with survival and regulates tumor progression in breast cancer［J］. Blood Adv， 2023， 7（11）： 2388-2400.
[21]	DAHA M R， SEELEN M. Novel approaches to control of the alternative complement pathway for the treatment of C3 glomerulopathies［J］. J Am Soc Nephrol， 2018， 29（8）： 2032-2033.
[22]	COSS S L， ZHOU D L， CHUA G T， et al. The complement system and human autoimmune diseases［J］. J Autoimmun， 2023， 137： 102979.
[23]	AYKUT B， PUSHALKAR S， CHEN R N， et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL［J］. Nature， 2019， 574（7777）： 264-267.
[24]	郭楠楠，王兴智. 补体B因子的研究进展［J］. 国际免疫学杂志， 2022， 45（1）： 6.
[25]	路平，魏少忠，梁新军. 补体系统与肿瘤免疫的研究进展［J］. 中国肿瘤临床， 2021， 48（13）： 681-685.
[26]	陈立颖，朱莹，封奕，等. 结肠癌组织中补体C5a/C5aR通路活化上调FGL2的表达［J］. 第三军医大学学报， 2016， 38（6）： 575-579.
[27]	WU P， SHI J Y， SUN W， et al. The prognostic value of plasma complement factor B （CFB） in thyroid carcinoma［J］. Bioengineered， 2021， 12（2）： 12854-12866.
[28]	MANTOVANI A， ALLAVENA P， MARCHESI F， et al. Macrophages as tools and targets in cancer therapy［J］. Nat Rev Drug Discov， 2022， 21（11）： 799-820.

Primer	Forward（5'-3'）	Reverse（5'-3'）
C1q	GAAGGGCGTGAAAGGCAATC	CAAGCGTCATTGGGTTCTGC
C2	AGAGTGCCGAACTCATGGTG	GGCTGAGAGGCAAAGGTGAT
C3	ATAAAGAGCCAGCGGCTACA	GAATGAAGGGGTAAGGGGCA
C3aR	CCCCAAGACATTGCCTCCAT	GACTGTGTTCACGGTCGTCT
C5	TGGTTCCTTCAGCACGACTC	CAGACTGCGTCAGCCACTAA
C5aR	TCCTTCAGAAGAGTTGCCTGC	TTCTGTGGTAACCAGCGACG
DAF	GCTCAATTAACTGCGGCTCAA	ACAGAGACAGCGACAGCAAC
FB	ATGGGGACAAGAAAGCCAGTT	TAGCCTTGGGCCTTTGTAGC
FD	TCGAAGGTGTGGTTACGTGG	TCGATCCACATCCGGTAGGA
GADPH	AATGCATCCTGCACCACC	ATGCCAGTGAGCTTCCCG

Bioinformatics analysis on adjustment effect of colorectal liver metastases model in mice based on complement alternative pathway and its experimental verification

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 13

References 28

Related Articles 15

Metrics

Comments

Recommended 0

[1]	Wenchang CAI,Yuqi LIU,Han WANG,Helin WANG,Zhenjiang WANG,Zishen XIAO,Shiyuan MA,Liping AN,Yanbo LIU. Expression of protein kinase D2 in bladder cancer tissue and its effect on tumor immune microenvironment [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 378-391.
[2]	Bo LIU,Chao SUN,Xu WANG,Kewei MA. Bioinformatics analysis on differentially expressed genes in multiple primary lung cancers based on GEO database [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 437-446.
[3]	Xiaoyan WANG,Xuelian LI,Bin LIANG,Wenfei TIAN,Hailin MA,Zhijing MO. Analysis on relationship between CALU and prognosis of hepatocellular carcinoma patients and its mechanism based on transcriptome and single cell sequencing data [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 447-459.
[4]	Huaxia MU,Weixiao BU,Shuting DING,Mengyao GAO,Weiqiang SU,Zhen ZHANG,Qifu BO,Feng LIU,Fuyan SHI,Qinghua WANG,Yujia KONG,Suzhen WANG. Two sample Mendelian randomization study on causal relationship between insulin-like growth factor-1 and colorectal cancer [J]. Journal of Jilin University(Medicine Edition), 2025, 51(2): 479-485.
[5]	Pengli WU,Fengyu LI,Bo LIU,Yang LYU. Effect of silencing DDX39A gene on proliferation, migration and invasion of esophageal cancer TE-1 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 115-123.
[6]	Lyuyin SUN,Zhuping MA,Runlin LI,Yonggang LI,Xiaoli TAO. Screening of host proteins interacting with Nelson Bay orthoreovirus σNS based on yeast two-hybrid technology [J]. Journal of Jilin University(Medicine Edition), 2024, 50(5): 1313-1321.
[7]	Jinlian LI,Lanzhen HUANG,Xishi HUANG,Kangzhi LI,Jiali JIANG,Miaomiao ZHANG,Qunying WU. Bioinformatics analysis on key genes related to prognosis, diagnosis， and immune cell infiltration of hepatocellular carcinoma and their potential therapeutic drugs [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1062-1075.
[8]	Yuanguo WANG,Peng ZHANG. Bioinformatics analysis based on relationship between SSP1 and TGFB1 and occurrence, prognosis, and immune invasion of esophageal adenocarcinoma [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1076-1086.
[9]	Linghui LIN,Na LI,Xiaoyan YIN,Xiaoling WANG,Yaping HU,Wei LIU,Rui FEI,Xinli TIAN. Bioinformatics anlysis based on three-dimensional structure of Helicobacter pylori hp0169 gene [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 739-748.
[10]	Zijia ZHU,Xia CHEN,Man CUI,Jihong WEN,Ping WANG,Dong SONG. Bioinformatics and molecular docking technology analysis on mechanism of salidroside on key differential genes of triple negative breast cancer [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 759-769.
[11]	Yuting LIU,Ying YU,Guizhen LI,Qinxue SHI,Binbin LI. Bioinformatics analysis based on expression of splicing factor SRSF9 in head and neck squamous cell carcinoma and clinical significance [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 379-391.
[12]	Liping CHEN,Li HAN,Hua BIAN,Liye PANG. Bioinformatics analysis based on differentially expressed genes and screening of traditional Chinese medicine for treatment of severe bronchial asthma [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 411-421.
[13]	Minqi NING,Yong HE,Bingshu LI,Guotao HUANG,Xiaohu ZUO,Zhihan ZHAO,Wuyue HAN,Li HONG. Bioinformatics analysis based on pelvic organ prolapse related aging genes of GEO Database and LASSO regression algorithm [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 178-187.
[14]	Zixu YANG,Chang SU,Boyuan WANG,Chong LIU,Minghe LI. Bioinformatics analysis on molecular subtypes and clinical characteristics of head and neck squamous cell carcinoma based on genes associated with lactate metabolism [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 198-207.
[15]	Yaqi XU,Yanyu WANG,Wenjing ZHANG,Mei HAN,Huaxia MU,Xi YANG,Weixiao BU,Zikun TAO,Yujia KONG,Fuyan SHI,Suzhen WANG. Bioinformatics analysis on screening of key genes of hepatitis B virus-related hepatocellular carcinoma and its relationship with prognosis [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1243-1252.